FDG PETCT in colorectal cancer

Author(s): Dr Rohit Kochhar, Dr Prakash Manoharan

Hospital: The Christie NHS Foundation Trust

Reference: RAD Magazine, 42, 491, 16-17


Colorectal cancer represents the second most common malignancy worldwide, with approximately one million newly diagnosed cases each year, and is the fourth leading cause of cancer mortality. This article provides an overview of the role of FDG (fluorodeoxyglucose) PET (positron emission tomography) CT (computed tomography) for assessment in patients with colorectal cancer.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more